Eye Specialist Oculis Launching Four Key Clinical Studies

CEO Says Transformative Trials Will Trigger Partnering Talks

Oculis believes it can deliver the first topical drug for retinal edema • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D